AR882 is an investigational selective uric acid transporter 1 inhibitor. The Food and Drug Administration (FDA) has granted Fast Track designation to AR882 for the treatment of clinically visible ...

The gout market is poised for steady growth, driven by the rising prevalence of the disease, increasing awareness, and the launch of novel therapies such as AR-882, Epaminurad, XNW3009, XRx-026, ...

SINGAPORE and PRINCETON, N.J., July 25, 2025 /PRNewswire/ -- Shanton Pharma, a clinical-stage biotech company developing a novel treatment for gout, today announced that FDA has designated its ...

If you suffer from gout, you know that flare-ups are uncomfortable and distressing. Symptoms like sudden pain, inflammation, and sensations of heat can turn a good day into a difficult one. If you're ...

ALLN-346 is an investigational, first-in-class, nonabsorbed, orally-administered enzyme that breaks down urate in the gastrointestinal tract. The Food and Drug Administration (FDA) has granted Fast ...

During the Neogene period, our ancestors produced a useful enzyme that lowered uric acid levels. Gene-editing is reviving ...

Gout could be treated by an ancient gene that humans lost millions of years ago, suggests new research. A form of arthritis caused by crystals that build up in joints and cause swelling and pain, gout ...